改良B-Lynch缝合术治疗产后出血的临床效果与安全性分析

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (31 KB)
Export: BibTeX | EndNote (RIS)

Abstract [Abstract]Objective To investigate the clinical efficacy and safety of modified B-Lynch suture for postpartum hemorrhage.Methods A total of 126 puerperae suffering from postpartum hemorrhage in our hospital from March 2015 to April 1818 were selected as the study subjects.According to the different hemostasis methods,they were divided into the control group(68 cases)and the observation group(58 cases).In the control group,the conventional gauze packing was used for hemostasis,while in the observation group,patients were treated with modified B-Lynch suture for hemostasis.The operation time,intraoperative blood loss,hospital stay,24-hour postpartum hemorrhage volume,hemoglobin changes before and after surgery,and the incidence of complications such as infection,intestinal obstruction,and intestinal adhesion within two weeks after surgery were observed and recorded between the two groups.Results There were no significant differences in the operation time and preoperative hemoglobin levels between the two groups(P＞0.05).The intraoperative blood loss and the 24-hour postpartum bleeding in the observation group were lower than those in the control group,with statistical significance (P＜0.05).The hospital stay in the observation group was significantly shorter compared with that of the control group,with a statistical difference (P＜0.05).The incidence of complications in the observation group was significantly lower than that of the control group,with a significant difference (P＜0.05).The postoperative hemoglobin level in the observation group was significantly higher than those in the control group,with statistical significance (P＜0.05).Conclusion Modified B-Lynch suture can effectively reduce the amount of bleeding during and 24 hours after surgery,shorten the hospital stay,and effectively reduce the incidence of postoperative complications,which is worthy of clinical application.

Key words： Cesarean section Modified B-Lynch suture Postpartum hemorrhage Complications

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2019/V26/I7/156

[1]	王茜，王晓秋.改良B-Lynch缝合术联合阴道填纱治疗剖宫产后出血的疗效及安全性[J].中国性科学，2016，25（4）：115-117.
[2]	姜长丽，张金芝，梁彦.B-lynch缝合术对产后出血的防治效果[J].中国现代医学杂志，2017，27（7）：132-135.
[3]	冯明先，徐婷，周琳.B-Lynch缝合术在治疗剖宫产产后出血的可行性及临床疗效分析[J].世界最新医学信息文摘，2018，18（23）：60-61.
[4]	余瑞梅，马永萍，廖珍华.子宫B-Lynch缝合技术治疗剖宫产产后出血的疗效及对预后的影响[J].中国妇幼保健，2017，32（24）：6327-6330.
[6]	陈志敏，孙凯，江华.改良式B-Lynch缝合术治疗剖宫产术中出血的临床应用价值及预后观察[J].中国性科学，2017，26（2）：105-108.
[8]	梁叆琳，钟华，黄新.改良B-Lynch子宫缝合治疗产后出血[J].现代医药卫生，2018，34（7）：1075-1077.
[5]	Ramírezcárdenas A，Solístrasancos H，Paola G，et al.Modified technique b-lynch compression suture with uterine atony[J].Ginecologia Y Obstetricia De Mexico，2015，83（8）：471-476.
[7]	Tower AM，Cronin B.Myomectomy after a vaginal delivery to treat postpartum hemorrhage resulting from an intracavitary leiomyoma[J].Obstetrics Gynecol，2015，125（5）：1110-1113.
[9]	Borrel G，Parisot N，Harris HM，et al.Comparative genomics highlights the unique biology of Methanomassiliicoccales，a Thermoplasmatales-related seventh order of methanogenic archaea that encodes pyrrolysine[J].BMC Genomics，2014，15（1）：1-24.
[10]	刘会芹，赵润果，王芳，等.产后出血相关危险因素分析与治疗方法比较[J].河北医药，2018，37（5）：748-751.
[11]	赵静.子宫B-Lynch缝合技术对剖宫产产后出血的治疗价值[J].中国当代医药，2018，25（16）：121-123.
[12]	Ryan MS，Shih SC，Winther CH，et al.Does it get easier to use an EHR?Report from an urban regional extension center[J].J General Int Med，2014，29（10）：1341-1348.
[13]	ChaiVY，ToWW.Uterine compressions utures for management of severe postpartum haemorrhage：five-year audit[J].Hong Kong Med J，2014，20（2）：113.
[14]	Tadakawa M，Sugawara J，Saito M，etal.Fertility and pregnancy outcomes following B-Lynch sutures for postpartum hemorrhage[J].J Obstetrics Gynaecol Res，2015，41（4）：559-564.
[15]	ReyesHD，ThielKW，CarlsonMJ，etal.Comprehensive profiling of EGFR/HER receptors for personalized treatment of gynecologic cancers[J].Mol Diagn Ther，2014，18（2）：137-151.